Purchases and Sales Made in Q3 2023 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q3 2023. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 09, 2023
Q3 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
1.33K+ 3.29% |
$10.6K - $20.4K
|
41.8K
$262K
|
|
Nov 13, 2023
Q3 2023
|
Ameritas Investment Partners, Inc.
Lincoln, NE |
BUY
|
- |
926+ 55.88% |
$7.4K - $14.2K
|
2.58K
$16.2K
|
|
Nov 09, 2023
Q3 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
830+ 3.96% |
$6.63K - $12.7K
|
21.8K
$136K
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
758+ 27.91% |
$6.06K - $11.6K
|
3.47K
$21.8K
|
|
Nov 21, 2023
Q3 2023
|
Comerica Bank
|
BUY
|
- |
467New |
$3.73K - $7.17K
|
467
$2.93K
|
|
Nov 13, 2023
Q3 2023
|
American International Group, Inc.
New York, NY |
BUY
|
- |
464+ 3.68% |
$3.71K - $7.13K
|
13.1K
$82K
|
|
Oct 26, 2023
Q3 2023
|
Macroview Investment Management LLC
|
BUY
|
- |
331New |
$2.64K - $5.08K
|
331
$2.08K
|
|
Nov 14, 2023
Q3 2023
|
Legal & General Group PLC
London, X0 |
BUY
|
- |
91+ 3.44% |
$727 - $1.4K
|
2.73K
$17.1K
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 31, 2023
Q3 2023
|
Levin Capital Strategies, L.P.
New York, NY |
SELL
|
- |
-500- 2.44% |
$4K - $7.68K
|
20K
$125K
|
|
Nov 14, 2023
Q3 2023
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-900- 1.38% |
$7.19K - $13.8K
|
64.2K
$403K
|
|
Nov 09, 2023
Q3 2023
|
Essex Investment Management CO LLC
Boston, MA |
SELL
|
- |
-2.79K- 1.33% |
$22.3K - $42.8K
|
207K
$1.3M
|
|
Nov 14, 2023
Q3 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-2.93K- 33.67% |
$23.4K - $45.1K
|
5.78K
$36.2K
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-4.68K- 36.1% |
$37.4K - $71.9K
|
8.29K
$52K
|
|
Nov 09, 2023
Q3 2023
|
Citigroup Inc
|
SELL
|
- |
-7.79K- 99.85% |
$62.2K - $120K
|
12
$75.2
|
|
Nov 07, 2023
Q3 2023
|
New York State Common Retirement Fund
|
SELL
|
- |
-7.91K- 50.41% |
$63.2K - $121K
|
7.78K
$48.8K
|
|
Nov 09, 2023
Q3 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-9.74K- 16.28% |
$77.8K - $150K
|
50.1K
$314K
|
|
Nov 13, 2023
Q3 2023
|
Bard Associates Inc
Chicago, IL |
SELL
|
- |
-11.6K- 37.73% |
$92.5K - $178K
|
19.1K
$120K
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-12.5KClosed |
$99.9K - $192K
|
0
$0
|
|
Nov 14, 2023
Q3 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-35K- 23.01% |
$280K - $538K
|
117K
$734K
|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-45.7K- 2.57% |
$366K - $703K
|
1.74M
$10.9M
|
|
Nov 08, 2023
Q3 2023
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-45.8K- 15.34% |
$366K - $704K
|
253K
$1.59M
|
|
Nov 14, 2023
Q3 2023
|
Acuta Capital Partners, LLC
Belmont, CA |
SELL
|
- |
-81.9K- 21.43% |
$654K - $1.26M
|
300K
$1.88M
|
|
Nov 14, 2023
Q3 2023
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-118K- 31.24% |
$941K - $1.81M
|
259K
$1.62M
|
|
Nov 14, 2023
Q3 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-135K- 43.43% |
$1.08M - $2.08M
|
176K
$1.1M
|
|
Jun 03, 2024
Q3 2023
|
Vontobel Holding Ltd.
|
SELL
|
- |
-140K- 44.28% |
$1.12M - $2.15M
|
176K
$1.1M
|
|
Oct 10, 2023
Q3 2023
|
Vontobel Holding Ltd.
|
SELL
|
- |
-140K- 44.28% |
$1.12M - $2.15M
|
176K
$1.1M
|
|
Nov 14, 2023
Q3 2023
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
SELL
|
- |
-700K- 16.7% |
$5.59M - $10.8M
|
3.49M
$21.9M
|
|
Nov 13, 2023
Q3 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-912K- 18.01% |
$7.29M - $14M
|
4.15M
$26M
|